Sign in

Filings

Finds words inside filing documents. Searching InMed Pharmaceuticals Inc.'s filings · 76 documents indexed.

9 documents · 81 matches

  1. INM InMed Pharmaceuticals Inc. 10-K 2026-09-09

    Item 1A. Risk Factors

    going concern may materially and adversely affect the price of our Common Shares, and it may be more difficult for us to obtain
    15 matches in this document
  2. INM InMed Pharmaceuticals Inc. 10-K 2025-09-23

    Item 1A. Risk Factors

    going concern may materially and adversely affect the price of our Common Shares, and it may be more difficult for us to obtain
    16 matches in this document
  3. INM InMed Pharmaceuticals Inc. 10-K 2022-09-23

    Item 1A. Risk Factors

    going concern may materially and adversely affect the price of our common shares, and it may be more difficult for us to obtain
    13 matches in this document
  4. INM InMed Pharmaceuticals Inc. 10-Q 2026-11-03

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
    7 matches in this document
  5. INM InMed Pharmaceuticals Inc. 10-Q 2026-05-06

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
    8 matches in this document
  6. INM InMed Pharmaceuticals Inc. 10-Q 2026-02-11

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
    7 matches in this document
  7. INM InMed Pharmaceuticals Inc. 10-Q 2025-11-06

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
    7 matches in this document
  8. INM InMed Pharmaceuticals Inc. 10-Q 2025-05-12

    Item 1 · Note 1. Corporate Information and Continuing Operations

    going concern considerations in accordance with Subtopic 205-40, management has determined that the Company’s liquidity condition raises substantial
    7 matches in this document
  9. INM InMed Pharmaceuticals Inc. 8-K 2025-06-13

    Item 4.01. Changes in Registrant’s Certifying Accountant

    inclusion of an explanatory paragraph regarding the substantial doubt about the Company’s ability to continue as a going concern.
    1 match in this document

Page 1 of 1 · 9 documents